Gaurav Prakash M.D. (@drgprakash) 's Twitter Profile
Gaurav Prakash M.D.

@drgprakash

Medical Oncologist, Prof, PGI-Chandigarh. Dedicated to help cancer patients & develop Medical Oncology at PGIMER, Chandigarh. Tweets personal. Likes 🚴‍♂️ & 🏃‍

ID: 435979304

calendar_today13-12-2011 17:09:12

5,5K Tweet

3,3K Followers

706 Following

OncoAlert (@oncoalert) 's Twitter Profile Photo

The #ASCO25 #OncoAlertTOP10 Abstracts in #GUOncology These are some of our picks of TOP abstracts we look forward to be presented at the upcoming ASCO Meeting in Chicago 🇺🇸 #ProstateCancer #BladderCancer #kidneyCancer ⭐Abs 4518 SURE-02: NEOADJUVANT SACITUZUMAB GOVITECAN PLUS

The #ASCO25 #OncoAlertTOP10 Abstracts in #GUOncology  These are some of our picks of TOP abstracts we look forward to be presented at the upcoming ASCO Meeting in Chicago 🇺🇸 
#ProstateCancer #BladderCancer #kidneyCancer

⭐Abs 4518 SURE-02: NEOADJUVANT SACITUZUMAB GOVITECAN PLUS
ESMO Open (@esmo_open) 's Twitter Profile Photo

Health-related quality-of-life profile and clinical outcomes in first-line advanced RCC: a modeling analysis based on the CheckMate 9ER study in ESMO Open. Three subgroups based on symptoms&risk profile, tx efficacy associated with HRQoL. esmoopen.com/article/S2059-…

Health-related quality-of-life profile and clinical outcomes in first-line advanced RCC: a modeling analysis based on the CheckMate 9ER study in <a href="/ESMO_Open/">ESMO Open</a>. Three subgroups based on symptoms&amp;risk profile, tx efficacy associated with HRQoL. esmoopen.com/article/S2059-…
Gaurav Prakash M.D. (@drgprakash) 's Twitter Profile Photo

Blinatumomab is a shot-in-arm for leukemia docs treating ALL. The following graphic provides useful information about its approval timeline.

Gaurav Prakash M.D. (@drgprakash) 's Twitter Profile Photo

Gradually, we are understanding ILD potential of TDXd better. In Destiny Gastro, ILD was manageable. Better outcomes were noted with TDXd based therapy over Ramucirumab + CT

Gaurav Prakash M.D. (@drgprakash) 's Twitter Profile Photo

Our Dept of Cl Hematology & Medical Oncology at #PGI organised an event with school and college students against tobacco. 🚭🚭 ▶️Our fight against cancer is relentless and it shall continue on all fronts ▶️Prevention is the most important aspect #NoTobaccoDay #HealthyChoices

Cancer Survivors Day (@survivorsday) 's Twitter Profile Photo

Cancer survivorship isn’t about just being alive after cancer. It’s about living life as fully as possible. Today, on #NationalCancerSurvivorsDay, June 1, let’s come together to #CelebrateLife and bring attention to the ongoing challenges cancer survivors face. #NCSD2025 #NCSD

Cancer survivorship isn’t about just being alive after cancer. It’s about living life as fully as possible. Today, on #NationalCancerSurvivorsDay, June 1, let’s come together to #CelebrateLife and bring attention to the ongoing challenges cancer survivors face.

#NCSD2025 #NCSD
Gaurav Prakash M.D. (@drgprakash) 's Twitter Profile Photo

Enfortumab Vedotin has two unique side effects 1. Skin rash 2. Change in taste Neuropathy is well known with MMAE (vedotin) Both EV 301 and 302 trials show survival advantage.

Gaurav Prakash M.D. (@drgprakash) 's Twitter Profile Photo

Happy #worldcycleday. 🚲 🚴‍♂️ 🚵‍♂️ 🌳 🏡 3rd June, 2025 If we all can bicycle to work at least one day per week then it will addup .

Happy #worldcycleday. 🚲 🚴‍♂️ 🚵‍♂️  🌳 🏡 
3rd June, 2025 

If we all can bicycle to work at least one day per week then it will addup .
Gaurav Prakash M.D. (@drgprakash) 's Twitter Profile Photo

Our Study on PK and PD comparing low dose venetoclax 50mg vs. 400mg in AML unfit for 3+7. ⭕️Ven50 led to similar CR and MRD negative rate as with Ven 400. ⭕️with lesser toxicity. Search is on for the optimal dose & plasma levels of venetoclax for AML induction #leusm ASCO

The Better India (@thebetterindia) 's Twitter Profile Photo

On June 7, 1893, a young Indian lawyer was thrown off a train in South Africa. That moment changed the destiny of millions. Mohandas Karamchand Gandhi, just 23 at the time, held a valid first-class ticket. But a white passenger objected to sharing space with a man of "coolie"

On June 7, 1893, a young Indian lawyer was thrown off a train in South Africa. That moment changed the destiny of millions. 

Mohandas Karamchand Gandhi, just 23 at the time, held a valid first-class ticket. But a white passenger objected to sharing space with a man of "coolie"
Gaurav Prakash M.D. (@drgprakash) 's Twitter Profile Photo

Apart from cardiac and metabolic diseases, obesity is also a risk factor for cancer. 🚶‍♂️ 🏃‍♀️ 🚴‍♂️ 🏊‍♀️ Above all help 🙏🙏 #HealthForAll #ONCSM Ministry of Health

Gaurav Prakash M.D. (@drgprakash) 's Twitter Profile Photo

RECOVER 60 was probably the first clinical trial which showed impact of low vitamin D on survival of cancer patients suffering from DLBCL #Lymsm

Gaurav Prakash M.D. (@drgprakash) 's Twitter Profile Photo

That tiny grub is turning into a monster. Colonic cancers are being diagnosed in much younger individuals. Report from TIME magazine

Gaurav Prakash M.D. (@drgprakash) 's Twitter Profile Photo

#Kesari2 will be worth your time. On the money. Brilliant acting by most actors and wonderfully directed. जय हिंद 🇮🇳